Mounjaro 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FP3JK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,636
Award facts
- Contract value 100% obligated
- $28,635.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,635.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen auto-injectors on September 2, 2025, with completion targeted for September 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through the DLA's Medical Supply Chain. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. As a child contract under the larger SPE2DX IDC, this delivery order reflects AmerisourceBergen's role as a primary pharmaceutical vendor supporting the Defense Health Agency and other federal healthcare systems. The company's federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements for specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains at varying price points and volumes.
Quick answers
Who was awarded contract SPE2DB25FP3JK?
SPE2DB25FP3JK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FP3JK worth?
The government has obligated $28,636 on SPE2DB25FP3JK.
Is contract SPE2DB25FP3JK an order under another contract?
Yes. SPE2DB25FP3JK is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB25FP3JK competed?
The extent of competition for SPE2DB25FP3JK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award